Insights

Friday Market Insights – Continued rotation into economically sensitive sectors

hand scrolling on phone with financial chat on it,
Share on facebook
Share on Facebook
Share on twitter
Make a Tweet
Share on linkedin
Share on LinkedIn
Watch our Friday Market Insights – Continued rotation into economically sensitive sectors, with Jill Bester and Wayne Wachell

This week's questions:

[00:23] : Share with us what we’ve seen in the market this week.

[01:15] : I expect we’re going to see continued rotation within the market until they get that approval through. What are your thoughts?

[02:19] : So what kind of changes have we made to the portfolio based on this movement we’re seeing between the dividend

[03:46] : How how do you forecast that work actually see through this after the pandemic has come to a manageable position?

[04:51] : Where do you think long term we’re going to look to see where the oil ends?

[05:53] : Where is the Canadian dollar to US dollar? Do you think it’s going to go over the next short term?

[06:38] : Are we currently positioned at holding Physer or Moderna and of course a large health care sector waiting still?

Jill Bester: [00:00:04] Welcome to our Friday Market Update. My name is Jill Bester. I am an Associate Portfolio Manager with Genus Capital Management, and I’m joined here this afternoon with our Chief Investment Officer and CEO, Wayne Wachell. Good afternoon, Wayne.

 

Wayne Wachell: [00:00:20] Hi.

 

Jill Bester: [00:00:21] What a week we’ve had. Share with us what we’ve seen in the market this week.

Wayne Wachell: [00:00:26] Well, this week the market went sideways, but there was a lot of internal rotation. And I would say the risk on trade is is still there. The economic cyclical stocks did did better than the tech companies. Energy financials all did well, as did the commodities. And it was about kind of a week where more risk on small cap did did well as well. And for the week, it’s still more of a risk on environment discounting the positive news from the back seat of last week.

 

Jill Bester: [00:00:57] All right. That’s interesting and exciting news with the vaccine announcement. I see this afternoon the FDA is looking into their approval of the Pfizer vaccine and they’re going to make their decision, it looks like, around December 10th. So with that news, I expect we’re going to see continued rotation within the market until they get that approval through. What are your thoughts?

 

Wayne Wachell: [00:01:23] There’s there’s good good news out there. It’s always, as they say, there’s it’s always darkest before the dawn. And with the current spike in covid, there are some concerns, but generally that the market is discounting a recovery in the overall market next next year and also the coming advent of vaccines. And so we’ve seen a big pop in the value trade to speed up companies that were hurt by covid and growth slowed down and actually come off a bit. And there could be that kind of volatility, I think, until we get more visibility through through this whole current outbreak here. But longer term into next year, we still see you see the value stocks doing a bit better and the smaller caps doing better with risk on tech environment. It’s a longer term play with volatility along the way, and that’s just the way it is. But I think the market is discounting a recovery and a vaccine coming to bear on the economy and the population.

 

Jill Bester: [00:02:18] Right. So what kind of changes have we made to the portfolio based on on this movement we’re seeing between the dividend, which would be kind of the covid losers, and then the Ken Global Fund with our covid winners overconcentrate in the growth?

 

Wayne Wachell: [00:02:36] Well, we made some some changes and in two ways. Number one, we’ve actually purchased more of the dividend strategy with our balance mandates, took it from cash, put it into there. And we also within our with our CanGlobe Fund, our growthy fund, we did some rotation out of technology into the more economic sensitive areas like financials, industrials and some materials. So some rotation. They were getting ready for longer term, we think, improvement in the economy and some of these areas as we push through the this pandemic.

 

Jill Bester: [00:03:09] Right. We also saw, obviously, Mr. Ford in Ontario make the call this afternoon in regards to a lockdown of Toronto. With that news, obviously, that’s going to have major impact on small business and they’re doing additional funding, federal and provincial funding. With that though, that’s going to increase our deficit long term. And obviously with a little bit of inflation pressure that we’re seeing, the consumer price index rose this week based on the cost of food. How how do you forecast that work actually see through this after the pandemic has come to a manageable position?

 

Wayne Wachell: [00:03:54] Well, this is like going through a war in some ways. And to fight that war, the government spending a lot of money as they do in most other wars, and it’ll take a long time to pay the debt off. Tax will probably go up somewhat, but you never solve your problems with taxation. We’re going to grow our way out of this problem. That’s usually what happens to being sort of buckling our belts, tighten our belts and growing the economy and longer term, getting the ratio of debt to the economy down by just by growth and not in less spending. So it’s going to be a long term proposition. But that’s what happens during these kinds of events.

 

Jill Bester: [00:04:28] Right. We call our Canadian dollar the petro currency, obviously based on our overweight in the energy sector, on the TSX. Where do you forecast, if you can forecast this based on the slowing intentionally the economy where oil will set long term? We’re over forty two dollars a barrel still. But with the slowdown potentially based on Lockdown’s, where do you think long term we’re going to look to see where the the oil ends?

 

Wayne Wachell: [00:04:56] Well, I still think the pandemic has changed the game completely in terms of travel business travel. Folks are going to spend more time working at home using Zoom to go into work. I think there’ll be less business travel because of bad consumer, how we changed our practices. So the demand for oil has definitely peaked and that’s what we’re seeing some forecasters out there saying. And so I think it’s going to put a lid on oil during tight spots. Well, could spike up to maybe sixty dollars in this range here. I think longer term, you’re looking at futures four or five years out there. Forty five to forty seven dollars in that range. So I think that this pandemic has changed the game for energy longer term. And there’s also more technology out there as well. That’s renewables are changing demand as well for oil. So I think it’s longer term, it’s it’s less optimistic for oil than it was before the pandemic.

 

Jill Bester: [00:05:50] Right. And with that, I actually had a client pose the question, where is the Canadian dollar to US dollar? Do you think it’s going to go over the next short term?

 

Wayne Wachell: [00:06:00] Well, typically, when the economy, the global economy improves, it’s more of a risk on environment and international trade improves. Canada does better in that kind of environment. I would say, and the oil makes it better. How what happens with oil? But oil should do well this year reasonably well this year as the economy improves. So we see some strength into it into into next year. I’m not sure how far I can go, maybe to 80 cents of that, but it should do a bit better in the next year. There might be some chop along the way through this COVID spike here, but through through next year it should do OK.

 

Jill Bester: [00:06:37] Right. Are we currently positioned at holding Physer or Moderna and of course a large health care sector waiting still?

 

Wayne Wachell: [00:06:45]  We overweight those overweight that sector. We went overweight. We’re still overweight in our sector. And it didn’t have a great week because Amazon came out this week with an idea of actually starting to sell drugs. And so that that definitely hurt a lot of drug companies. And so they’re also get squeezed, we think, through new and improved some of the new proposals we’re seeing in the US health care industry. But we have an overweight net in that sector. We don’t have much Pfizer. We have some Merck, Regeneron about generally overweight that space.

 

Jill Bester: [00:07:20] Right. On that note, obviously, Dr Barney Henry has put down further restrictions across the province, not just in the Lower Mainland and Fraser Valley. So with that, I’d like to wish everyone well, obviously, it’s a time of great concern for many of us. And at this point, I think we’ll call it a day. Wayne, thank you again for your time. And we’d like to thank you as our customers as well as our prospects. If you have any questions, please feel free to reach out to your portfolio manager. Thank you very much and stay safe home. Thank you, Wayne.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email

Client impact

“Graduating from a big bank to Genus was one of the best financial steps we've ever taken. Genus has delivered reliable asset growth despite our moderate risk tolerance. As our financial security has grown, we've also been the beneficiaries of a great client experience. The company's communications have been consistently transparent and informative, including educational webinars and a well-designed web portal where we can track investments daily. Most importantly to us, our portfolio manager has always responded swiftly and thoroughly to our questions and requests. ”
Martin T.
"Having relatively diverse financial goals and needs, along with a slight reticence regarding the stock market, Genus skillfully addressed all of our concerns, and put together a truly exceptional plan: Fossil free funds and a diversified investment portfolio, check; An effective Impact investment portfolio that coincides with our hopes and dreams for a better world, check; Professional advice and assistance to create a donor advised charitable fund with immediate charitable receipts for tax purposes, check. Returns? Way beyond our expectations! We even had some fun along the way and certainly enjoyed an incredible two-year start to what will be a satisfying long-term relationship with Genus."
Marc B.
“I love the service I get at Genus.”
Chris H.
“Leslie and I were fellow board members when we met twenty years ago. For the last ten she has been thoughtful in the construction of an investment strategy for my family and is executing the strategy as planned. The team at Genus has met my expectations and are a pleasure to deal with.”
Bob Q.
“For over 15 years, I have provided selection and performance evaluation of multiple investment managers for a significant family office. Leslie and Genus have been foundational for me in my role. I have always found Leslie and her colleagues to be insightful and proactive, and found the performance of their portion of the portfolio to be well above benchmarks. And they have been a great pleasure to work with.”
Douglas H.
“Genus is a very innovative firm. I am pleased to invest in their Fossil Free and Impact strategies that help me invest in line with my values.”
Marnie C.
“Great team of professionals. Excellent website and reporting. Responds to inquiries promptly. Very pleased with the process of changing from another company to Genus as well. Kudos.”
David L.
“Genus consistently provides a good, clearly explained, comprehensive picture of the general economic and financial situation, along with an excellent account of the investment decisions made in relation to this. Genus’ equally strong concern with clients’ questions and requests for further information is also a very important part of the service it provides.”
Allan S.
“Back in 1992 when I found myself at fifty with a substantial amount of money to invest, I knew just one thing — that I didn’t want to contribute to tobacco companies, arms manufacturers, or oil. But over the ensuing years the options for socially responsible investing have become far more sophisticated and I’m very happy that this is a big part of the Genus approach. I also very much appreciate the long-term relationship with my portfolio manager, Mary Lou.”
Ann P.

As seen in

Are you ready to make an impact
with your investments
?